Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?

Published:2012-12-11 Issue:2 Volume:35 Page:181-184
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Todd Adam,Williamson Steve,Husband Andy,Baqir Wasim,Mahony Mairead

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

http://link.springer.com/content/pdf/10.1007/s11096-012-9731-2.pdf

Reference16 articles.

1. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38:666–71.

2. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, et al. Adverse drug events in high-risk older outpatients. J Am Geriatr Soc. 1997;45:945–8.

3. Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol. 2011;12:1249–57.

4. Riechelmann RP, Zimmermann C, Chin SN, Wang L, O’Carroll A, Zarinehbaf S, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manag. 2008;35:535–43.

5. Girre V, Arkoub H, Puts MT, et al. Potential drug interactions in elderly cancer patients. Potential drug interactions in elderly cancer patients. Crit Rev Oncol Hematol. 2011;78:220–6.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing polypharmacy in older adults with cancer: A pilot cluster-randomized trial protocol;Journal of Geriatric Oncology;2024-03

2. A systematic scoping review of interventions to optimise medication prescribing and adherence in older adults with cancer;Research in Social and Administrative Pharmacy;2022-03

3. Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer;Journal of Oncology Pharmacy Practice;2021-04-07

4. Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors;Journal of Geriatric Oncology;2021-01

5. Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy;Journal of Cancer Research and Clinical Oncology;2020-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3